Skip Navigation

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines & 3rd Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts


Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

One Goal, One Passion: Therapeutic Development for NeuroHIV Illustrated brain advance to content

The interdisciplinary research team at the Johns Hopkins NIMH Center for Novel Therapeutics for HIV-associated Cognitive Disorders is dedicated to studying such conditions as HIV-associated dementia, asymptomatic neurocognitive impairments and mild neurocognitive disorders. We aim to translate discoveries of the pathophysiological mechanisms of these conditions into novel therapeutics, as well as provide resources to other HIV researchers across Johns Hopkins Medicine institutions.

Contact Us

Please contact our program administrator Heather Thomas with any questions about the center: 443-287-0571.


Funding Disclosure

Then JHU NIMH Center for Novel Therapeutics for HIV-associated Cognitive Disorders is funded by a P30 Grant from the National Institute of Mental Health (P30MH075673). The content and research presented on this website is solely the responsibility of the authors and does not necessarily represent the views of the National Institutes of Health.

back to top button